Fractionated microneedle radiofrequency versus botuinum toxin A in primary axillary hyperhidrosis
Phase 1
Recruiting
- Conditions
- Skin and Connective Tissue Diseases
- Registration Number
- PACTR201808213089174
- Lead Sponsor
- Reem Osama Eid
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
1.Patients older than 18 years.
2.Patients with bilateral PAH grade 3 and 4 hyoerhidrosis disease severity score (HDSS)
Exclusion Criteria
1.History of surgery for PAH.
2.History of botulinum toxin therapy within the previous 6 months.
3.History of pacemaker implantation or any other electronic implants.
4.Active infection in the treatment area.
5.Tendency for keloid formation.
6.Pregnancy or breastfeeding.
7.Neuromuscular disease e.g. myasthenia gravis.
8.Known hypersensitivity from Botulinum toxin.
9.Autoimmune disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparative clinical effectiveness at 1, 2, 3 and 6 months, in the form of reduction of sweating in the treated site
- Secondary Outcome Measures
Name Time Method 1.Comparative safety of both interventions during the procedure, short-term (0-6 months) and long-term (6-12 months).<br>2.Long-term comparative clinical effectiveness (6-12 months)<br>